|
TAF4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.396700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.819000E-03 |
| Normal-vs-Stage2 |
2.616200E-02 |
| Normal-vs-Stage3 |
3.85330000000073E-05 |
| Normal-vs-Stage4 |
3.103700E-03 |
| Stage1-vs-Stage2 |
9.564600E-01 |
| Stage1-vs-Stage3 |
3.789800E-02 |
| Stage1-vs-Stage4 |
4.844000E-01 |
| Stage2-vs-Stage3 |
1.713600E-01 |
| Stage2-vs-Stage4 |
6.109000E-01 |
| Stage3-vs-Stage4 |
4.004800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.629100E-04 |
| Normal-vs-AfricanAmerican |
1.011840E-01 |
| Normal-vs-Asian |
8.053600E-02 |
| Caucasian-vs-AfricanAmerican |
5.460200E-01 |
| Caucasian-vs-Asian |
2.819400E-01 |
| AfricanAmerican-vs-Asian |
8.602800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.577000E-03 |
| Normal-vs-Female |
5.006100E-04 |
| Male-vs-Female |
5.573800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.165550E-02 |
| Normal-vs-Age(41-60Yrs) |
1.283690E-03 |
| Normal-vs-Age(61-80Yrs) |
3.614500E-04 |
| Normal-vs-Age(81-100Yrs) |
3.199100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.182600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.771440E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.999700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.223600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.017160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.125000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.410400E-02 |
| Classical-VS-Follicular |
4.236100E-03 |
| Classical-VS-Other |
9.854600E-01 |
| Classical-VS-Normal |
1.791590E-02 |
| Tall-VS-Follicular |
9.258600E-01 |
| Tall-VS-Other |
4.385200E-01 |
| Tall-VS-Normal |
5.365500E-04 |
| Follicular-VS-Other |
3.889400E-01 |
| Follicular-VS-Normal |
1.829210E-04 |
| Other-VS-Normal |
3.673600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.822200E-04 |
| Normal-vs-N1 |
4.936900E-03 |
| N0-vs-N1 |
8.128400E-01 |
|
|
